Protocol Design Featured Articles

31. Understanding Lupus Trial Participation And The Importance Of Patient Support 2/27/2025

    Lupus Therapeutics Director of Patient Engagement Caroline Donovan explores the challenges of patient enrollment and heralds the role of patient support in running successful trials for lupus patients.

32. Day One Bio's Talks With FDA Help Secure Glioma Drug Approval 2/14/2025

    Day One CMO Elly Barry, MD recounts the company's experience working with the FDA and turning a passed-over drug into its first-ever approved treatment for pediatric glioma patients.

33. Harness MDIC's Collaborative Resources to Strengthen Clinical Trials and Patient Outcomes 2/13/2025

    Discover how resources from the Medical Device Innovation Consortium (MDIC) can help advance clinical trials for better patient outcomes.

34. Roche Diagnostics Guides New Alzheimer's Test Through Trials 2/12/2025

    Roche Diagnostics’ Maria-Magdelena Patru, MD, PhD discusses their plasma test and how they’re approaching its clinical trials. 

35. How PDS Biotech Approached FDA Meetings For Its Phase 3 Cancer Trial 2/11/2025

    PDS Biotech CMO Kirk Shepard reveals his team’s interactions with the FDA as it sought to begin its Phase 3 trial for the treatment of HPV-positive recurrent and/or metastatic head and neck squamous cell carcinoma.

36. Input Needed On Using AI To Create Lay Summaries Of Trial Results 2/7/2025

    CISCRP is soliciting feedback from research professionals, patients, and advocacy groups on its "Considerations for Using AI to Create Lay Summaries of Trial Results" until Feb. 18.

37. Annual SCOPE Summit Serves Up A Similar But Satisfying Menu 2/7/2025

    Executive editor Abby Proch sums up her second SCOPE Summit experience.

38. A Tool To Tackle The Risk Of Uninformative Trials 1/31/2025

    Uninformative trials hinder progress in clinical practice, policy decisions, and further research. Fast Data Science developed a free risk tool to help pharma companies avoid them.

39. In Clinical Research, Every Day Is Groundhog Day 1/30/2025

    Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.

40. Biopharma R&D Faces Productivity And Attrition Challenges In 2025 1/29/2025

    Evaluate VP of Thought Leadership Daniel Chancellor discusses trends for 2025 as the surge in R&D, coupled with rapidly evolving industry dynamics, presents a productivity and attrition challenge for the industry.